Get the Stockscreener App
4.78
0.62%
-0.03
After Hours:
4.81
0.03
+0.63%
Abeona Therapeutics Inc stock is traded at $4.78, with a volume of 1.29M.
It is down -0.62% in the last 24 hours and down -11.65% over the past month.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
See More
Previous Close:
$4.81
Open:
$4.79
24h Volume:
1.29M
Relative Volume:
1.26
Market Cap:
$245.11M
Revenue:
-
Net Income/Loss:
$-54.19M
P/E Ratio:
-1.8527
EPS:
-2.58
Net Cash Flow:
$-37.34M
1W Performance:
-13.72%
1M Performance:
-11.65%
6M Performance:
-27.13%
1Y Performance:
-23.52%
1-Day Range:
$4.655
$4.855
1-Week Range:
$4.655
$5.54
52-Week Range:
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Name
Abeona Therapeutics Inc
Sector
Industry
Phone
646-813-4701
Address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Compare ABEO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
4.78 | 246.65M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Mar-05-25 | Initiated | Oppenheimer | Outperform |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| May-30-24 | Initiated | Stifel | Buy |
| Nov-11-20 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-18-20 | Initiated | B. Riley FBR | Buy |
| Feb-10-20 | Initiated | SVB Leerink | Outperform |
| Dec-10-19 | Resumed | Cantor Fitzgerald | Neutral |
| Aug-15-19 | Downgrade | Maxim Group | Buy → Hold |
| Aug-12-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-26-19 | Downgrade | Mizuho | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Oct-12-18 | Initiated | Mizuho | Buy |
| Jun-05-18 | Initiated | Seaport Global Securities | Buy |
| Nov-08-17 | Initiated | SunTrust | Buy |
| Oct-16-17 | Reiterated | H.C. Wainwright | Buy |
| Oct-11-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Oct-10-17 | Initiated | Citigroup | Buy |
| Oct-05-17 | Reiterated | Maxim Group | Buy |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Jul-18-17 | Reiterated | Maxim Group | Buy |
| Jun-22-17 | Resumed | Jefferies | Buy |
| Jan-06-17 | Initiated | Jefferies | Buy |
| Sep-29-16 | Reiterated | Maxim Group | Buy |
View All
Abeona Therapeutics Inc Stock (ABEO) Latest News
How Abeona Therapeutics Inc. stock reacts to job market dataCPI Data & Low Volatility Stock Recommendations - newser.com
What downside risks could hit Abeona Therapeutics Inc. (PCJ) stockJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - newser.com
Why retail investors favor Abeona Therapeutics Inc. stockQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Abeona Therapeutics (ABEO) Grants Equity Awards to New Employees - GuruFocus
Sector ETF performance correlation with Abeona Therapeutics Inc.Weekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Abeona Therapeutics (NASDAQ: ABEO) grants 71,035 restricted shares to 11 new employees - Stock Titan
Will Abeona Therapeutics Inc. stock benefit from green energy trendsRisk Management & Precise Buy Zone Tips - newser.com
Visualizing Abeona Therapeutics Inc. stock with heatmapsJuly 2025 Patterns & Risk Controlled Swing Alerts - newser.com
Sentiment analysis tools applied to Abeona Therapeutics Inc.July 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com
Can Abeona Therapeutics Inc. (PCJ) stock survive global slowdownMarket Risk Summary & Capital Protection Trade Alerts - newser.com
How Abeona Therapeutics Inc. stock reacts to inflationary pressuresSwing Trade & AI Driven Stock Price Forecasts - newser.com
Should I hold or sell Abeona Therapeutics Inc. stock in 2025Trade Risk Assessment & Daily Chart Pattern Signals - newser.com
Is Abeona Therapeutics Inc. (PCJ) stock supported by free cash flow2025 Stock Rankings & Safe Entry Trade Reports - newser.com
Is Abeona Therapeutics Inc. stock oversold or undervaluedWeekly Stock Recap & Weekly Setup with ROI Potential - newser.com
Applying big data sentiment scoring on Abeona Therapeutics Inc.July 2025 Closing Moves & Scalable Portfolio Growth Ideas - newser.com
Will Abeona Therapeutics Inc. (PCJ) stock benefit from Fed rate cutsBear Alert & AI Powered Buy and Sell Recommendations - newser.com
How dovish Fed policy supports Abeona Therapeutics Inc. (PCJ) stockPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com
CMS assigns permanent J-code for Abeona’s RDEB therapy ZEVASKYN By Investing.com - Investing.com Australia
Can Abeona Therapeutics Inc. stock sustain institutional interestTrade Analysis Report & Community Consensus Trade Signals - newser.com
Is Abeona Therapeutics Inc. stock positioned for long term growthQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
Is Abeona Therapeutics Inc. (PCJ) stock a top dividend aristocrat candidateQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Published on: 2025-10-31 02:43:41 - newser.com
Why Abeona Therapeutics Inc. (PCJ) stock could outperform next yearWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Abeona Therapeutics Inc. (ABEO) stock price, news, quote and history - Yahoo! Finance UK
Abeona Therapeutics Inc. (PCJ.F) stock price, news, quote and history - Yahoo! Finance Singapore
Abeona Therapeutics Gets Permanent CMS J-Code for Zevaskyn Gene Therapy - MarketScreener
Abeona Therapeutics Inc. Announces Permanent J-Code for ZEVASKYN® (prademagene Zamikeracel) - MarketScreener
Abeona Therapeutics announces permanent J-code for Zevaskyn (prademagene zamikeracel) - MarketScreener
Abeona Therapeutics Inc Stock (ABEO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):